|
Bio-Rad
cfx96 touchtm platforms Cfx96 Touchtm Platforms, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cfx96 touchtm platforms/product/Bio-Rad Average 99 stars, based on 1 article reviews
cfx96 touchtm platforms - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
|
Bioeksen R&D Technologies
bio-speedy ® direct rt-qpcr sars-cov-2 detection kit  Bio Speedy ® Direct Rt Qpcr Sars Cov 2 Detection Kit, supplied by Bioeksen R&D Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/bio-speedy ® direct rt-qpcr sars-cov-2 detection kit/product/Bioeksen R&D Technologies Average 90 stars, based on 1 article reviews
bio-speedy ® direct rt-qpcr sars-cov-2 detection kit - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Vaccines
Article Title: Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial
doi: 10.3390/vaccines10111865
Figure Lengend Snippet: Study flowchart. SARS-CoV-2, severe acute respiratory syndrome coronavirus-2; PCR, polymerase chain reaction; COVID-19, Coronavirus disease 2019.
Article Snippet: All participants had oropharyngeal and nasopharyngeal swabs for baseline PCR testing with
Techniques: Polymerase Chain Reaction
Journal: Vaccines
Article Title: Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial
doi: 10.3390/vaccines10111865
Figure Lengend Snippet: Seropositivity rates in the CoronaVac and TURKOVAC arms 14 days later than the second dose and its distribution according to age and sex: ( a ) for SARS-CoV-2 anti-spike IgG antibodies, ( b ) for pseudovirus neutralization assay. SARS-CoV-2, severe acute respiratory syndrome coronavirus-2; IgG, immunoglobulin G.
Article Snippet: All participants had oropharyngeal and nasopharyngeal swabs for baseline PCR testing with
Techniques: Neutralization